Next-generation nano-biosensors for hepatocellular carcinoma

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Hepatocellular carcinoma (HCC) is a major global cancer mortality cause, often diagnosed late.
• Current biomarkers for HCC lack sufficient sensitivity, hindering early detection and effective treatment.

Purpose of the Study:

• To review advancements in nanomaterial-based biosensors for HCC diagnostics.
• To highlight the potential of these biosensors in improving early detection, monitoring, and prognosis of HCC.

Main Methods:

• Review of current literature on nanomaterial biosensors for HCC.
• Focus on carbon nanostructures, metal-organic frameworks, quantum dots, and plasmonic nanoparticles.
• Analysis of biomarker detection (alpha-fetoprotein, glypican-3, nucleic acids) and multiplexed capabilities.

Main Results:

• Nanomaterial biosensors offer enhanced sensitivity and specificity for HCC biomarkers.
• Various nanomaterials show potential for detecting key HCC indicators.
• Platforms are being developed to bridge lab innovation with clinical application.

Conclusions:

• Nanomaterial biosensors represent a significant advancement for precision diagnostics in HCC.
• These technologies promise earlier detection, personalized monitoring, and better prognostic assessment.
• Further development and clinical validation are crucial for integrating these tools into standard care.